| 3F3V: Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type I reference: Hybrid compound design to overcome the gatekeeper T338M mutation in cSrc., Getlik M, Grutter C, Simard JR, Kluter S, Rabiller M, Rode HB, Robubi A, Rauh D, J Med Chem. 2009 Jul 9;52(13):3915-26. PMID: 19462975 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).